Terms: = Germ cell tumor AND DICER1, Dicer, 23405, ENSG00000100697, KIAA0928, HERNA, Q9UPY3, K12H4_8-LIKE AND Prognosis
19 results:
1. Silencing of dicer enhances dacarbazine resistance in melanoma cells by inhibiting ADSL expression.
Yeh YW; Hsu TW; Su YH; Wang CH; Liao PH; Chiu CF; Tseng PC; Chen TM; Lee WR; Tzeng YS
Aging (Albany NY); 2023 Nov; 15(22):12873-12889. PubMed ID: 37976135
[TBL] [Abstract] [Full Text] [Related]
2. Transfer RNA-derived small RNAs (tsRNAs) sequencing revealed a differential expression landscape of tsRNAs between glioblastoma and low-grade glioma.
Tu M; Zuo Z; Chen C; Zhang X; Wang S; Chen C; Sun Y
Gene; 2023 Mar; 855():147114. PubMed ID: 36526122
[TBL] [Abstract] [Full Text] [Related]
3. Results of the treatment of pineal tumors in children: the Lyon experience.
Szathmari A; Beuriat PA; Vasiljevic A; Leblond P; Faure-Conter C; Claude L; Di Rocco F; Mottolese C
Childs Nerv Syst; 2023 Sep; 39(9):2317-2327. PubMed ID: 36242638
[TBL] [Abstract] [Full Text] [Related]
4. Histopathology and molecular pathology of pediatric pineal parenchymal tumors.
Vasiljevic A
Childs Nerv Syst; 2023 Sep; 39(9):2273-2284. PubMed ID: 35972537
[TBL] [Abstract] [Full Text] [Related]
5. Embryonal tumors in the WHO CNS5 classification: A Review.
Gianno F; Miele E; Antonelli M; Giangaspero F
Indian J Pathol Microbiol; 2022 May; 65(Supplement):S73-S82. PubMed ID: 35562137
[TBL] [Abstract] [Full Text] [Related]
6. dicer1 mutations in primary central nervous system tumors: new insights into histologies, mutations, and prognosis.
Liu KX; Shang HH; Cacciotti C; Everdell E; Aizer AA; Rahman R; Malinowski S; Meredith DM; Kamihara J; Wen PY; Ligon KL; Chi SN; Marcus KJ; Yeo KK; Alexandrescu S; Haas-Kogan DA
J Neurooncol; 2022 May; 157(3):499-510. PubMed ID: 35384518
[TBL] [Abstract] [Full Text] [Related]
7. MiRNAs in early brain development and pediatric cancer: At the intersection between healthy and diseased embryonic development.
Prieto-Colomina A; Fernández V; Chinnappa K; Borrell V
Bioessays; 2021 Jul; 43(7):e2100073. PubMed ID: 33998002
[TBL] [Abstract] [Full Text] [Related]
8. Hereditary ovarian tumour syndromes: current update on genetics and imaging.
Shanbhogue KP; Prasad AS; Ucisik-Keser FE; Katabathina VS; Morani AC
Clin Radiol; 2021 Apr; 76(4):313.e15-313.e26. PubMed ID: 33353730
[TBL] [Abstract] [Full Text] [Related]
9. Clinical Characteristics and Mutation Analyses of Ovarian Sertoli-Leydig cell tumors.
Yuan Z; Huo X; Jiang D; Yu M; Cao D; Wu H; Shen K; Yang J; Zhang Y; Zhou H; Wang Y
Oncologist; 2020 Sep; 25(9):e1396-e1405. PubMed ID: 32557933
[TBL] [Abstract] [Full Text] [Related]
10. Modeling germline mutations in pineoblastoma uncovers lysosome disruption-based therapy.
Chung PED; Gendoo DMA; Ghanbari-Azarnier R; Liu JC; Jiang Z; Tsui J; Wang DY; Xiao X; Li B; Dubuc A; Shih D; Remke M; Ho B; Garzia L; Ben-David Y; Kang SG; Croul S; Haibe-Kains B; Huang A; Taylor MD; Zacksenhaus E
Nat Commun; 2020 Apr; 11(1):1825. PubMed ID: 32286280
[TBL] [Abstract] [Full Text] [Related]
11. The molecular landscape of ETMR at diagnosis and relapse.
Lambo S; Gröbner SN; Rausch T; Waszak SM; Schmidt C; Gorthi A; Romero JC; Mauermann M; Brabetz S; Krausert S; Buchhalter I; Koster J; Zwijnenburg DA; Sill M; Hübner JM; Mack N; Schwalm B; Ryzhova M; Hovestadt V; Papillon-Cavanagh S; Chan JA; Landgraf P; Ho B; Milde T; Witt O; Ecker J; Sahm F; Sumerauer D; Ellison DW; Orr BA; Darabi A; Haberler C; Figarella-Branger D; Wesseling P; Schittenhelm J; Remke M; Taylor MD; Gil-da-Costa MJ; Łastowska M; Grajkowska W; Hasselblatt M; Hauser P; Pietsch T; Uro-Coste E; Bourdeaut F; Masliah-Planchon J; Rigau V; Alexandrescu S; Wolf S; Li XN; Schüller U; Snuderl M; Karajannis MA; Giangaspero F; Jabado N; von Deimling A; Jones DTW; Korbel JO; von Hoff K; Lichter P; Huang A; Bishop AJR; Pfister SM; Korshunov A; Kool M
Nature; 2019 Dec; 576(7786):274-280. PubMed ID: 31802000
[TBL] [Abstract] [Full Text] [Related]
12. Two cases of primary supratentorial intracranial rhabdomyosarcoma with dicer1 mutation which may belong to a "spindle cell sarcoma with rhabdomyosarcoma-like feature, dicer1 mutant".
Sakaguchi M; Nakano Y; Honda-Kitahara M; Kinoshita M; Tanaka S; Oishi M; Noguchi K; Fukuda M; Maeba H; Watanabe T; Hayashi Y; Ikeda H; Minato H; Ichimura K; Nojima T; Nakada M
Brain Tumor Pathol; 2019 Oct; 36(4):174-182. PubMed ID: 31487013
[TBL] [Abstract] [Full Text] [Related]
13. Intraocular medulloepithelioma - A review of clinical features, dicer 1 mutation, and management.
Tadepalli SH; Shields CL; Shields JA; Honavar SG
Indian J Ophthalmol; 2019 Jun; 67(6):755-762. PubMed ID: 31124483
[TBL] [Abstract] [Full Text] [Related]
14. The prevalence of dicer1 pathogenic variation in population databases.
Kim J; Field A; Schultz KAP; Hill DA; Stewart DR
Int J Cancer; 2017 Nov; 141(10):2030-2036. PubMed ID: 28748527
[TBL] [Abstract] [Full Text] [Related]
15. Successful Management of a Patient with Malignant Thyroid Teratoma.
Rabinowits G; Barletta J; Sholl LM; Reche E; Lorch J; Goguen L
Thyroid; 2017 Jan; 27(1):125-128. PubMed ID: 27784193
[TBL] [Abstract] [Full Text] [Related]
16. Loss of tumor suppressors KAI1 and p27 identifies a unique subgroup of primary melanoma patients with poor prognosis.
Zhang G; Cheng Y; Chen G; Tang Y; Ardekani G; Rotte A; Martinka M; McElwee K; Xu X; Wang Q; Zhou Y
Oncotarget; 2015 Sep; 6(26):23026-35. PubMed ID: 26246476
[TBL] [Abstract] [Full Text] [Related]
17. CSF1-ETS2-induced microRNA in myeloid cells promote metastatic tumor growth.
Mathsyaraja H; Thies K; Taffany DA; Deighan C; Liu T; Yu L; Fernandez SA; Shapiro C; Otero J; Timmers C; Lustberg MB; Chalmers J; Leone G; Ostrowski MC
Oncogene; 2015 Jul; 34(28):3651-61. PubMed ID: 25241894
[TBL] [Abstract] [Full Text] [Related]
18. MiR-192 directly binds and regulates dicer1 expression in neuroblastoma.
Feinberg-Gorenshtein G; Guedj A; Shichrur K; Jeison M; Luria D; Kodman Y; Ash S; Feinmesser M; Edry L; Shomron N; Weizman A; Yaniv I; Avigad S
PLoS One; 2013; 8(11):e78713. PubMed ID: 24223844
[TBL] [Abstract] [Full Text] [Related]
19. microRNA signature and expression of dicer and Drosha can predict prognosis and delineate risk groups in neuroblastoma.
Lin RJ; Lin YC; Chen J; Kuo HH; Chen YY; Diccianni MB; London WB; Chang CH; Yu AL
Cancer Res; 2010 Oct; 70(20):7841-50. PubMed ID: 20805302
[TBL] [Abstract] [Full Text] [Related]
